Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Novo Nordisk A/S Class B (NOVCb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Novo Nordisk B historical data, for real-time data please try another search
58.66 +0.05    +0.09%
05/10 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 58.66 - 58.66
Type:  Equity
Market:  Germany
ISIN:  DK0060534915 
S/N:  A1XA8R
Novo Nordisk B 58.66 +0.05 +0.09%

Novo Nordisk A/S Latest Cash Flow Statement

 
Use the Novo Nordisk A/S Class B cash flow statement to assess the changes in NOVOb's cash and cash equivalents.

The NOVOb cash flow chart shows Net Income, Cash from Operating, Financing and Investing Activities, as well as Novo Nordisk B free cash flow, yield and ending cash balance.
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2014
30/06
2014
31/03
2013
31/12
2013
30/09
Period Length: 6 Months 3 Months 12 Months 9 Months
Net Income/Starting Line 13452 6458 25184 527.22
Cash From Operating Activities 12194 4069 25942 560.4
Depreciation/Depletion - - - 123.7
Amortization - - - -
Deferred Taxes - - - -
Non-Cash Items 5881 2023 10738 -53.09
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 4245 3272 9807 0.15
Cash Interest Paid 14 8 39 30.85
Changes in Working Capital -7139 -4412 -9980 -37.43
Cash From Investing Activities 547 416 -2773 -390.02
Capital Expenditures -1690 -801 -3644 -445
Other Investing Cash Flow Items, Total 2237 1217 871 54.98
Cash From Financing Activities -18707 -13176 -23639 -135.46
Financing Cash Flow Items - 2102 - -4.47
Total Cash Dividends Paid -11866 -11866 -9715 -320.69
Issuance (Retirement) of Stock, Net -6841 -3412 -13924 352.86
Issuance (Retirement) of Debt, Net - - - -163.16
Foreign Exchange Effects 48 14 -70 7
Net Change in Cash -5918 -8677 -540 34.91
Beginning Cash Balance - - - -
Ending Cash Balance - - - -
Free Cash Flow - - - -
Free Cash Flow Growth - - - -
Free Cash Flow Yield - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Price Commentary

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Roger Amrein
Roger Amrein Dec 19, 2022 14:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What do you mean?
Escobar Sy
Escobar Sy Dec 17, 2022 4:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how can we do it
Nov 02, 2022 22:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tjek dette
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email